Shantani Proteome Analytics Profile
Key Indicators
- Authorised Capital ₹ 2.40 M
- Paid Up Capital ₹ 0.93 M
- Company Age 14 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 121.89%
- Profit Growth 275.22%
- Ebitda 279.91%
- Net Worth 148.31%
- Total Assets 145.64%
About Shantani Proteome Analytics
Shantani Proteome Analytics Private Limited (SPAPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 12 May 2010 and has a history of 14 years and nine months. Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.40 M and a paid-up capital of Rs 0.93 M, as per Ministry of Corporate Affairs (MCA) records.
Vikas Saxena and Chaitanya Saxena serve as directors at the Company.
Company Details
- Location
Pune, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74900PN2010PTC136292
- Company No.
136292
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 May 2010
- Date of AGM
26 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Shantani Proteome Analytics?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vikas Saxena  | Director | 12-May-2010 | Current |
| Chaitanya Saxena | Whole-Time Director | 12-May-2010 | Current |
Financial Performance of Shantani Proteome Analytics.
Shantani Proteome Analytics Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 121.89% increase. The company also saw a substantial improvement in profitability, with a 275.22% increase in profit. The company's net worth Soared by an impressive increase of 148.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shantani Proteome Analytics?
In 2020, Shantani Proteome Analytics had a promoter holding of 85.99% and a public holding of 14.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Renishaw Metrology Systems LimitedVikas Saxena is a mutual person
Patheya FoundationVikas Saxena is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Shantani Proteome Analytics?
Shantani Proteome Analytics has a workforce of 0 employees as of May 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shantani Proteome Analytics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shantani Proteome Analytics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
